亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Cerebral Bypass for Aneurysms in the Era of Flow Diversion: Single-Surgeon Case Series

医学 改良兰金量表 血运重建 动脉瘤 闭塞 蛛网膜下腔出血 放射科 外科 内科学 缺血 缺血性中风 心肌梗塞
作者
Mohsen Nouri,Júlia Schneider,Kevin Shah,Timothy G. White,Jeffrey M. Katz,Amir R. Dehdashti
出处
期刊:Operative Neurosurgery [Oxford University Press]
卷期号:21 (5): 303-311 被引量:7
标识
DOI:10.1093/ons/opab215
摘要

Abstract BACKGROUND With recent advances in endovascular treatments of brain aneurysms such as flow diverters, the role of cerebral revascularization needs to be re-evaluated. OBJECTIVE To evaluate the contemporary indications and outcomes of cerebral revascularization for brain aneurysms. METHODS A retrospective evaluation of a prospectively maintained database was performed to review clinical and imaging data of all the patients who underwent cerebral revascularization for brain aneurysms over the past 10 yr. RESULTS Among 174 cerebral revascularizations, 40 (in 36 patients) were done for the treatment of aneurysms. In total, 9 patients underwent combined endovascular treatment and surgical revascularization. Immediate aneurysm occlusion was achieved in 30 patients (83.3%). Immediate postoperative bypass patency was confirmed in 33 patients (92%). Postoperative neurological deficit was observed in 4 patients (11.1%). There were 2 mortalities in the postoperative period. Aneurysm total occlusion rate was 91% at 1 yr. Thirty patients had 1 yr clinical and radiological follow-up. Clinical evaluations showed modified Rankin Scale 2 or less in 25 patients at 1 yr. Bypass patency was confirmed in 27 (90%). Patients with fair/poor outcome were all in the subarachnoid hemorrhage group. Twenty-one patients had follow-up studies for 3 yr or beyond with no evidence of stroke or aneurysm recurrence. CONCLUSION Our results support that cerebral revascularization can be regarded as a viable and durable treatment option for these challenging aneurysms with acceptable morbidity. Cerebral bypass should be offered in selected cases where standard endovascular or surgical treatment is not efficacious or curative.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈媛发布了新的文献求助10
16秒前
Uluru发布了新的文献求助30
23秒前
小二郎应助科研通管家采纳,获得10
56秒前
57秒前
1分钟前
老宇126完成签到,获得积分10
1分钟前
Dannnn完成签到 ,获得积分10
1分钟前
zai完成签到 ,获得积分20
1分钟前
清净163完成签到,获得积分10
1分钟前
2分钟前
xiaorui发布了新的文献求助10
2分钟前
小二郎应助xiaorui采纳,获得10
2分钟前
ppw完成签到 ,获得积分10
2分钟前
甜蜜发带完成签到 ,获得积分10
2分钟前
领导范儿应助科研通管家采纳,获得10
2分钟前
3分钟前
3分钟前
几米完成签到 ,获得积分10
3分钟前
4分钟前
斯文败类应助科研通管家采纳,获得10
4分钟前
Sair完成签到,获得积分10
5分钟前
bukeshuo发布了新的文献求助10
5分钟前
充电宝应助bukeshuo采纳,获得10
6分钟前
酷波er应助欣一采纳,获得10
6分钟前
吃不饱星球球长应助Sair采纳,获得50
6分钟前
可爱的函函应助整齐乐巧采纳,获得10
7分钟前
7分钟前
7分钟前
7分钟前
我爱科研发布了新的文献求助10
7分钟前
llpp发布了新的文献求助10
7分钟前
整齐乐巧发布了新的文献求助10
7分钟前
llpp完成签到,获得积分20
7分钟前
charliechen完成签到 ,获得积分10
8分钟前
情怀应助我爱科研采纳,获得10
9分钟前
迷你的靖雁完成签到,获得积分10
9分钟前
张桓完成签到,获得积分10
9分钟前
赘婿应助可靠的寒风采纳,获得10
10分钟前
10分钟前
我爱科研发布了新的文献求助10
10分钟前
高分求助中
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Becoming: An Introduction to Jung's Concept of Individuation 600
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Актуализированная стратиграфическая схема триасовых отложений Прикаспийского региона. Объяснительная записка 360
Project Studies: A Late Modern University Reform? 300
2024 Medicinal Chemistry Reviews 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3167162
求助须知:如何正确求助?哪些是违规求助? 2818660
关于积分的说明 7921824
捐赠科研通 2478380
什么是DOI,文献DOI怎么找? 1320299
科研通“疑难数据库(出版商)”最低求助积分说明 632748
版权声明 602438